stella
beta
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study — Stella
Recruiting
Back to Colorectal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov